Lord Glenarthur wrote to Clive Jenkins, stating "there is no conclusive evidence that AIDS is transmitted through blood products. Nevertheless we are taking all practicable measures to reduce any possible risks to recipients of blood and blood products". Read more about Lord Glenarthur wrote to Clive Jenkins, stating "there is no conclusive evidence that AIDS is transmitted through blood products. Nevertheless we are taking all practicable measures to reduce any possible risks to recipients of blood and blood products".
In a memo to Dr Walford, Mr Wrigglesworth (DHSS) queried whether further action was required on pre-March 1983 blood products as such products continued to be used in the USA. Read more about In a memo to Dr Walford, Mr Wrigglesworth (DHSS) queried whether further action was required on pre-March 1983 blood products as such products continued to be used in the USA.
Christopher Bishop stated in his oral evidence that Armour had no qualms internally about disposing of or selling pre-March 1983 product in the UK. Read more about Christopher Bishop stated in his oral evidence that Armour had no qualms internally about disposing of or selling pre-March 1983 product in the UK.
An internal Armour memo suggested it was "vitally important" that Armour sell the products manufactured from plasma collected prior to the March 1983 FDA memorandum as quickly as possible. Read more about An internal Armour memo suggested it was "vitally important" that Armour sell the products manufactured from plasma collected prior to the March 1983 FDA memorandum as quickly as possible.
In a memo, Dr Walford stated Dr Smith had "carefully worded [the] recommendation" of the CSM paper and "that supply of material must take precedence over [the] implementation [of CSM(B)'s recommendation]." Read more about In a memo, Dr Walford stated Dr Smith had "carefully worded [the] recommendation" of the CSM paper and "that supply of material must take precedence over [the] implementation [of CSM(B)'s recommendation]."
C Wrigglesworth requested Dr Walford's views on whether any action was required in relation to the stocks of pre-March 1983 material and suggested there was a conflict between the result of the FDA meeting and the 13 July CSM(B) recommendation. Read more about C Wrigglesworth requested Dr Walford's views on whether any action was required in relation to the stocks of pre-March 1983 material and suggested there was a conflict between the result of the FDA meeting and the 13 July CSM(B) recommendation.
A letter from Lord Glenarthur contemplated that future blood product supplies for the UK would not all be manufactured from pre-March 1983 plasma. Read more about A letter from Lord Glenarthur contemplated that future blood product supplies for the UK would not all be manufactured from pre-March 1983 plasma.
In an information sheet about AIDS it was stated that the DHSS Medicines and Supply Divisions were endeavouring to ensure that there would be no "dumping" of high-risk plasma products on the UK market. Read more about In an information sheet about AIDS it was stated that the DHSS Medicines and Supply Divisions were endeavouring to ensure that there would be no "dumping" of high-risk plasma products on the UK market.
An information sheet about AIDS prepared by Dr Diana Walford was provided to Lord Glenarthur. Read more about An information sheet about AIDS prepared by Dr Diana Walford was provided to Lord Glenarthur.
An information sheet about AIDS prepared by Dr Diana Walford was provided to John Patten. Read more about An information sheet about AIDS prepared by Dr Diana Walford was provided to John Patten.